Clinical Trial Update: Ketamine As an Adjunctive Therapy for Major Depression (2) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating ketamine as an adjunctive therapy for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University of Dublin, Trinity College | Conditions: Major Depressive Episode, Unipolar Depression | Phase 3 | Status: COMPLETED